Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970¿2010.
Human vaccines & immunotherapeutics: news.
Multimodal Therapy of Recurrent Severe Acute Disseminated Encephalomyelitis: The Role of Immunoadsorption.
Symptomatic management in multiple sclerosis.
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.
Cytokines and chemokines in multiple sclerosis.
Changing associations between cognitive impairment and imaging in multiple sclerosis as the disease progresses.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis.
Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis.
Possible second motor neuron damage in neuromyelitis optica.
Evolution of diagnostic criteria for multiple sclerosis.
Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.
Determinants of on-the-job-barriers in employed persons with multiple sclerosis: The role of disability severity and cognitive indices.
[Adaptative immunity and pathophysiology of multiple sclerosis.]
Impaired social cognition in multiple sclerosis.
Autophagy and neurodegeneration.
Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis.
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study.
Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.
MicroRNA in neurodegenerative drug discovery: the way forward?
Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.
Pages
« first
‹ previous
…
466
467
468
469
470
471
472
473
474
…
next ›
last »